Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hainan Shennong Seed Industry Technology
300189
5
Shanghai Menon Animal Nutrition Technology
301156
CN Stock MarketDetailed Quotes
688488 Jiangsu Aidea Pharmaceutical
- 9.93
- -1.29-11.50%
Noon Break Apr 7 11:29 CST
4.18BMarket Cap-40.04P/E (TTM)
10.70High9.77Low109.27KlotVolume10.31Open11.22Pre Close110.72MTurnover2.60%Turnover RatioLossP/E (Static)420.78MShares17.3352wk High3.91P/B4.18BFloat Cap6.5852wk Low13.46Limit Up420.78MShs Float45.21Historical High8.98Limit Down8.29%Amplitude6.58Historical Low--Dividend TTM10.13Avg Price62.87KlotAsk--Div YieldTTM100Lot Size40.66KlotBid
Jiangsu Aidea Pharmaceutical News
Eddy Pharmaceutical\'s announcement on the completion of the general election of the company\'s board of directors and board of supervisors and the appointment of senior management and securities affairs representatives
Legal Opinion of Jiangsu Century Tongren Law Firm on the 2025 First Extraordinary General Meeting of Shareholders of Jiangsu Eddy Pharmaceutical Co., Ltd.
Announcement of Resolutions of Eddy Pharmaceutical\'s 2025 First Extraordinary General Meeting of Shareholders
Eddy Pharmaceuticals: Eddy Pharmaceuticals 2025 First Extraordinary Shareholders\' Meeting Meeting Information
Eddy Pharmaceuticals 2025 First Extraordinary Shareholders\' Meeting Meeting Information
Eddy Pharmaceuticals: Eddy Pharmaceuticals Independent Director Nominee Statement and Commitment - Guo Zijian
Eddy Pharmaceuticals: Eddy Pharmaceuticals Independent Director Candidate Statement and Commitment - Shao Yiming
Eddy Pharmaceuticals: Eddy Pharmaceuticals Independent Director Nominee Statement and Commitment - Shao Yiming
Eddy Pharmaceuticals: Eddy Pharmaceuticals Independent Director Candidate Statement and Commitment - Guo Zijian
Eddy Pharmaceuticals: Eddy Pharmaceuticals Board Nomination Committee\'s Review Opinions on Independent Director Candidates for the 3rd Board of Directors
Eddy Pharmaceuticals: Eddy Pharmaceuticals Announcement on the Retirement and Resignation of Senior Management and Core Technicians and the Adjustment of the Company\'s Core Technicians
Eddy Pharmaceuticals: Eddy Pharmaceuticals Announcement on Board of Directors and Supervisory Board Elections
Eddy Pharmaceuticals: Eddy Pharmaceuticals Announcement on Election of Staff Representative Supervisors for the 3rd Board of Supervisors
Eddy Pharmaceuticals: Notice of Eddy Pharmaceuticals to convene the first extraordinary shareholders\' meeting in 2025
Eddy Pharmaceuticals: Eddy Pharmaceuticals Independent Director Nominee\'s Statement and Commitment - Qi Xiaoyan
Eddy Pharmaceuticals: Eddy Pharmaceuticals Independent Director Candidate Statement and Commitment - Qi Xiaoyan
Notice of Eddy Pharmaceuticals to convene the first extraordinary shareholders\' meeting in 2025
Eddy Pharmaceutical\'s Announcement on Election of Staff Representative Supervisors for the 3rd Board of Supervisors
Eddy Pharmaceutical\'s announcement on the election of the board of directors and board of supervisors
Legal Opinion of Jiangsu Century Tongren Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Jiangsu Eddy Pharmaceutical Co., Ltd.